Tech Company Financing Transactions
Torque Funding Round
Flagship Pioneering participated in a $25 million Series A funding round for Torque. The round was announced on 11/15/2017.
Transaction Overview
Company Name
Announced On
11/15/2017
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Flagship Pioneering (Douglas Cole)
Proceeds Purpose
Proceeds purposes were not disclosed, but the company launched its technology platform concurrently with the funding announcement.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
450 Kendall St.
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
Torque is developing a new class of Deep-Primed immune cell therapeutics for the treatment of cancer. We use a technology platform to anchor powerful biotherapeutics--stimulatory cytokines, antibodies, and small molecules--directly to immune cells to direct and evoke immune cell responses, locally in the tumor microenvironment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bart Henderson
Chief Medical Officer
Becker Hewes
Chief Operating Officer
Alex Bruni
Chief Scientific Officer
Thomas Andresen
Vice President
Karsten Sauer
VP - Bus. Development
Tapan Maniar
VP - General Counsel
Jennifer Camacho
VP - Manufacturing
Fabio Fachin
VP - Manufacturing
Eden Fucci
Browse more venture capital transactions:
Prev: 11/15/2017: Genialis venture capital transaction
Next: 11/15/2017: Locus Biosciences venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs